Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc. (NASDAQ:ALAB), completed a series of automatic sales of company common stock on April 1, 2026, disposing of 9,900 shares for aggregate proceeds of $1.07 million. The disposition was carried out under a pre-established Rule 10b5-1 trading arrangement that Mazzara adopted on May 29, 2025.
The sales were executed at a range of prices. Transaction-level detail shows 3,100 shares sold at an average of $106.3426, 1,985 shares at $107.5416, 3,415 shares at $108.4046, 1,000 shares at $109.156, and 500 shares at $110.346. These weighted average prices together produced the $1.07 million total value reported.
Following the April 1 trades, Mazzara directly holds 118,084 shares of Astera Labs common stock. The trades were automatic under the Rule 10b5-1 framework, meaning they were pre-arranged and executed in accordance with the plan's parameters.
The stock has experienced meaningful swings in recent periods. Over the past six months ALAB has fallen 42%, while over the trailing 12 months it has climbed 110%. At the time of the filing, the share price was quoted at $117.14, which is above the range of prices at which Mazzara sold his shares on April 1.
In valuation commentary included with the disclosure, InvestingPro analysis flagged ALAB as appearing overvalued relative to its Fair Value and noted there are 16 additional ProTips available to subscribers. The platform also advertises a comprehensive Pro Research Report that covers ALAB among more than 1,400 U.S. equities for subscribers seeking further detail.
Separately, Astera Labs reported fourth-quarter 2025 financial results that exceeded consensus earnings expectations. The company posted earnings per share of $0.58, which was 13.73% higher than the $0.51 forecast. Revenue for the quarter reached $270.6 million, representing year-over-year growth of 92%. Those operating results were highlighted alongside the insider transaction but were reported without additional commentary on their effect on the stock price.
Summary
Astera Labs' general counsel sold 9,900 shares under a Rule 10b5-1 plan on April 1, 2026, for $1.07 million. The stock has shown large short- and long-term moves, trading at $117.14 after the sale, and the company reported strong Q4 2025 earnings and revenue growth.
Key points
- Mazzara sold 9,900 shares on April 1, 2026, totaling $1.07 million under a Rule 10b5-1 plan adopted May 29, 2025.
- The sales were executed across five price points; Mazzara retains direct ownership of 118,084 shares after the transactions.
- ALAB stock has been volatile - down 42% over six months but up 110% over one year - and the company reported Q4 2025 EPS of $0.58 and revenue of $270.6 million, a 92% year-over-year increase.
Risks and uncertainties
- Market volatility: ALAB's substantial six-month decline and one-year gain indicate price volatility that can affect shareholders and market perception.
- Valuation concerns: InvestingPro analysis indicates the stock appears overvalued relative to its Fair Value, which could influence investor appetite.
- Insider selling optics: Although the trades were executed under a pre-arranged plan, insider sales can be interpreted in different ways by market participants, potentially impacting sentiment in the technology and capital markets sectors.